dipropizine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These results confirmed the respiratory safety of levodropropizine 6% drops administered at the recommended dosage either in healthy volunteers or patients with chronic respiratory impairment." | 2.71 | Levodropropizine does not affect P0.1 and breathing pattern in healthy volunteers and patients with chronic respiratory impairment. ( Bruschi, C; Crotti, P; Dacosto, E; Daffonchio, L; Fanfulla, F; Novellini, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruschi, C | 1 |
| Crotti, P | 1 |
| Dacosto, E | 1 |
| Fanfulla, F | 1 |
| Daffonchio, L | 1 |
| Novellini, R | 1 |
1 trial available for dipropizine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Levodropropizine does not affect P0.1 and breathing pattern in healthy volunteers and patients with chronic respiratory impairment.
Topics: Adult; Antitussive Agents; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Propylene | 2003 |